BMS-337039
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-337039, covering 2013-11-08 to 2013-11-08. Get the full timeline:
Most recent: Clinical Trial Update: A Switch Study of BMS-337039 in Schizophrenic Out-patients [Phase 4]